A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion
- PMID: 29221292
- PMCID: PMC5708377
- DOI: 10.21037/jtd.2017.08.52
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion
Abstract
Background: In a patient with pleural effusion, cytological study (CS) is one of the most useful investigations, especially when malignancy is suspected. Instead of applying only CS, the pleural fluid can be further processed using the cell block (CB) technique, which may augment the diagnostic utility. The aim of this study was to compare the diagnostic yields of CS, CB, and the combination of both, regardless of the etiology of pleural effusion.
Methods: A cross-sectional study was conducted on patients with pleural effusions who underwent thoracentesis from June 2015 to May 2016. All samples were submitted for routine biochemical analysis, CS, and CB histology. The results of cytopathological studies were compared to the final diagnoses.
Results: Out of a total of 353 samples, the final diagnoses included 278 (78.8%) malignancies, 41 (11.6%) infectious diseases, 16 (4.5%) other inflammatory diseases, and 18 (5.1%) transudative pleural effusions. CS and CB provided a similar diagnostic yield (48.7% vs. 49.9%, P=0.69), while the combination of both gave a higher yield (57.2%) (P<0.001, compared with CS). Among 278 malignant pleural effusions (MPE), the diagnostic yields of CS and CB were 61.2% and 61.9%, respectively. Combined CS and CB improved the diagnostic yield to 71.2% (P<0.001). However, both CS and CB had low diagnostic yields in infectious pleuritis, other inflammatory diseases, and transudative pleural effusions.
Conclusions: In MPE, CB provides a similar diagnostic performance to CS, while application of both techniques can significantly increase the diagnostic yield. However, in other pleural diseases, CB and CS had limited values in diagnosis.
Keywords: Cell block (CB); cytology; malignant pleural effusion (MPE); pleural effusion.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures

Similar articles
-
A Comparative Study of Liquid-Based Cytology and DNA Image Cytometry in the Diagnosis of Serous Effusion.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820942298. doi: 10.1177/1533033820942298. Technol Cancer Res Treat. 2020. PMID: 32856543 Free PMC article.
-
Contribution of Cell Block Obtained by Thoracentesis in the Diagnosis of Malignant Pleural Effusion.J Cytol. 2019 Oct-Dec;36(4):205-208. doi: 10.4103/JOC.JOC_99_18. Epub 2019 Jun 11. J Cytol. 2019. PMID: 31741579 Free PMC article.
-
Clinicopathological Study of 117 Body Fluids: Comparison of Conventional Smear and Cell Block Technique.Curr Health Sci J. 2020 Oct-Dec;46(4):336-343. doi: 10.12865/CHSJ.46.04.03. Epub 2020 Dec 31. Curr Health Sci J. 2020. PMID: 33717507 Free PMC article.
-
Pleural diseases.Dis Mon. 1992 May;38(5):266-331. doi: 10.1016/0011-5029(92)90007-c. Dis Mon. 1992. PMID: 1572232 Review.
-
Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.Clin Biochem. 2016 Nov;49(16-17):1227-1231. doi: 10.1016/j.clinbiochem.2016.08.006. Epub 2016 Aug 10. Clin Biochem. 2016. PMID: 27521620 Review.
Cited by
-
ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion.Diagnostics (Basel). 2021 Aug 12;11(8):1463. doi: 10.3390/diagnostics11081463. Diagnostics (Basel). 2021. PMID: 34441397 Free PMC article.
-
Diagnostic benefits of the combined use of liquid-based cytology, cell block, and carcinoembryonic antigen immunocytochemistry in malignant pleural effusion.J Thorac Dis. 2018 Aug;10(8):4931-4939. doi: 10.21037/jtd.2018.07.139. J Thorac Dis. 2018. PMID: 30233867 Free PMC article.
-
An uncommon cause of pleural effusion.Breathe (Sheff). 2019 Jun;15(2):e84-e89. doi: 10.1183/20734735.0365-2018. Breathe (Sheff). 2019. PMID: 31777569 Free PMC article.
-
Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion.Tanaffos. 2021 Mar;20(3):221-231. Tanaffos. 2021. PMID: 35382086 Free PMC article.
-
Beyond diagnosis: a narrative review of the evolving therapeutic role of medical thoracoscopy in the management of pleural diseases.J Thorac Dis. 2024 Mar 29;16(3):2177-2195. doi: 10.21037/jtd-23-1745. Epub 2024 Mar 27. J Thorac Dis. 2024. PMID: 38617786 Free PMC article. Review.
References
-
- Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2013;143:e142S-65S. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources